Skip to main content
S&P 5007,376.86+0.31%DOW51,285.73-0.46%NASDAQ24,579.42+1.09%BTC$75,946.00-0.25%ETH$2,243.57+0.21%GOLD$4,079.50-0.83%OIL$90.34-0.20%
Smart Investors Daily
SID Premium
Twist Bioscience Corporation logo

NASDAQ · TWST

Twist Bioscience Corporation

Healthcare · Medical - Diagnostics & Research

$120.79

Up+$0.18 (+0.15%)

Updated Nov 7, 2026, 5:32 AM

SID Score

5.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.92B
P/E ratio
-25.04
Dividend yield
0.00%
52-week range
$41.52 – $219.71
Volume
2.06M
Avg. volume
1.74M

Price performance · TWST

TWST price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 6, 2026

TWST closed at $120.79 after 21 trading sessions, down 24.40% for the selected period.

Last close
$120.79
Period change
-24.40%
Period low
$120.61
Period high
$173.45
Daily close
View OHLC price history
TWST OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 6, 2026$123.83$130.90$116.50$120.792.06M
Nov 5, 2026$134.79$134.975$118.60$120.613.09M
Nov 4, 2026$140.78$142.98$131.32$142.582.01M
Nov 3, 2026$130.35$141.62$130.14$140.301.94M
Nov 2, 2026$153.17$154.225$128.29$129.042.67M
Oct 30, 2026$162.94$167.27$148.00$152.783.4M
Oct 29, 2026$170.43$177.99$169.07$173.451.78M
Oct 28, 2026$160.44$178.53$159.00$173.453.49M
Oct 27, 2026$145.74$162.61$143.70$159.851.76M
Oct 26, 2026$139.45$147.6228$136.19$145.251.38M
Oct 23, 2026$132.95$140.74$131.23$139.921.86M
Oct 22, 2026$143.50$150.14$131.85$135.472.69M
Oct 21, 2026$139.335$153.80$138.25$149.132.64M
Oct 20, 2026$139.77$148.83$134.94$142.702.02M
Oct 19, 2026$136.99$141.80$133.72$139.771.59M
Oct 16, 2026$143.88$145.05$130.9825$132.752.83M
Oct 15, 2026$138.09$148.32$130.6798$144.493.54M
Oct 14, 2026$146.69$156.00$144.79$148.162.12M
Oct 13, 2026$149.00$154.23$146.00$151.331.53M
Oct 12, 2026$159.78$161.80$147.5522$151.862.65M
Oct 9, 2026$152.69$168.93$152.1375$159.783.54M

Latest TWST news

The latest Smart Investors Daily articles mentioning TWST.

Stock researchCompany · Overview

TWST research

Overview

Company profile and research snapshot.

Company profile

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$42.33
Implied upside
—
Analysts
—
TWST recent ratings
DateFirmRatingTarget
Oct 13, 2026TD CowenBuy—
Oct 12, 2026Canaccord GenuityBuy—
Oct 8, 2026JefferiesHold—
Oct 7, 2026BarclaysOverweight—
Oct 1, 2026GuggenheimBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 3, 2026

Twist Bioscience (TWST) Following MRD Express Launch Has An Undervalued Narrative But Pricey Sales

What Twist MRD Express Could Mean For Twist Bioscience Stock Twist Bioscience (TWST) just rolled out Twist MRD Express, a customizable panel platform for molecular residual disease research that targets cancer-focused labs needing faster, more personalized test development at scale. Twist Bioscience has had a sharp pullback, with the share price down 15.54% over the last day and 31.61% over the past month. However, the 90 day share price return of 29.76% and year to date gain of 298.39% keep...

Yahoo · Nov 3, 2026

Twist Bioscience (TWST) Debuts MRD Express For Faster Personalized Cancer Panel Research

Twist Bioscience (NasdaqGS:TWST) introduced Twist MRD Express, a new personalized molecular residual disease panel service for cancer research. The offering focuses on rapid production of custom MRD detection panels intended for use in oncology and liquid biopsy studies. Twist MRD Express targets researchers seeking scalable workflows to monitor cancer recurrence using individualized genetic signatures. There is more to Twist Bioscience than the new Twist MRD Express launch for personalized...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By